Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04IBG
|
|||
| Former ID |
DIB006327
|
|||
| Drug Name |
Infanrix-DTaP-IPV-Hep B
|
|||
| Synonyms |
Pediarix; Infanrix PeNta; Infanrix PeNta-Hep B-IPV
Click to Show/Hide
|
|||
| Indication | Bordetella pertussis infection [ICD-11: 1C12.0; ICD-10: A37.0] | Approved | [1], [2] | |
| Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Approved | [1] | ||
| Company |
SmithKline Beecham plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00454987) Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.